The FY2025 (Dec) proxy of Mimedx Group names 18 peer companies for pay. Among Mimedx Group and these peers, CEO pay was 4th highest of 7 and total shareholder return was 5th highest of 7.
4th highest of 7in Mimedx Group and its pay peers, FY2025 (Dec) by CEO pay:
$5.5M$10.3M
5th highest of 7in Mimedx Group and its pay peers, FY2025 (Dec) by total shareholder return:
$26$193
Pay peer group, FY2025 (Dec) proxy
| Alphatec Holdings | ||
| Adma Biologics | ||
| Veracyte | ||
| CareDx | ||
| Artivion | ||
| Angiodynamics | ||
| AVITA Medical, Inc. | Not disclosed | Not disclosed |
| Anika Therapeutics | Not disclosed | Not disclosed |
| Axonics, Inc. | Not disclosed | Not disclosed |
| Bioventus Inc. | Not disclosed | Not disclosed |
| Integra Life Sciences Holdings Corporation | Not disclosed | Not disclosed |
| OraSure Technologies, Inc. | Not disclosed | Not disclosed |
| Organogenesis Holdings Inc. | Not disclosed | Not disclosed |
| Orthofix Medical | Not disclosed | Not disclosed |
| Outset Medical, Inc. | Not disclosed | Not disclosed |
| Standard BioTools Inc. | Not disclosed | Not disclosed |
| Tactile Systems Technology, Inc. | Not disclosed | Not disclosed |
| Vericel | Not disclosed | Not disclosed |
18 companies
PSU comparator group
The companies that relative total shareholder return is measured against for performance stock units.
| Russell 2000 Index (index) | Not disclosed | Not disclosed |
1 company
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.